ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Madopar 250, Tabletten - 30 Tablette(n)
43593013 Roche Pharma (Schweiz) AG
Madopar 250, Tabletten27.01.1981
Original27.01.1981
Levodopa and Decarboxylase Inhibitor (N04BA02)12.02.2004
WHO-DDD 
01.08.30 Tablette(n)
01.08. 
B  
Yes 
IPCI
8.76No
    
10 %18.60
7680435930139Synthetika
896321 
Composition
levodopum 200.00 mg, benserazidum 50.00 mg ut benserazidi hydrochloridum, mannitolum, calcii hydrogenophosphas, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, ethylcellulosum, E 172 (rubrum), silica colloidalis anhydrica, natrii docusas corresp. natrium 0.01 mg, magnesii stearas, pro compresso.
Teilbarkeit
 Ja (Bruchrille) 
 Nein 
 Nein 
 -- 
 Teilbar entlang der Bruchkerbe, aber nicht weiter zerkleinern. Vorschlag: Madopar LIQ (= wasserlösliche Tabletten) verwenden. [2] 
 
[2] Firmeninformation
th_part
Tablets 
 
Active AgentDose
Benserazide50 mg
Levodopa200 mg
BAG: Active AgentDose
Benserazide50 mg
Levodopa200 mg
 
Inactive agents additional_information
(Rubrum)  
Amylum Pregelificatum  
Calcium Hydrogen Phosphate  
Cellulosum Microcristallinum  
Crospovidonum  
E 172 color.
Ethylcellulosum  
Magnesii Stearas  
Mannitol  
Natrii Docusas  
Pro Compresso  
Silica Colloidalis Anhydrica  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home